SCIESCOPUSQ1
Journal of Psychopharmacology
SAGE PUBLICATIONS LTD, ENGLAND
Journal profile
- CiteScore
- 9.90
- Scopus citation metric
- Percentage rank
- 91.1%
- JIF percentile rank
- SJR
- 1.708
- SCImago rank
- SNIP
- 1.37
- Source normalized impact
- ISSN
- 0269-8811
- Publisher
- SAGE PUBLICATIONS LTD
- eISSN
- 1461-7285
- Country
- ENGLAND
- Abbreviation
- J. Psychopharmacol.
- Languages
- ENGLISH
- Index coverage
- SCIE, SCOPUS
- Overall rank
- -
- Web of Science categories
- SCIE · CLINICAL NEUROLOGY, NEUROSCIENCES, PHARMACOLOGY & PHARMACY, PSYCHIATRY
- JCI
- 1.37
- Scopus ASJC categories
- 2736 Pharmacology (medical), 2738 Psychiatry and Mental Health, 3004 Pharmacology
- Keywords
- Clinical Neurology, Neurosciences, Pharmacology & Pharmacy, Psychiatry, Neuroscience & Behavior, Neurosciences & Behavior, Pharmacology (medical), Psychiatry and Mental health
Journal of Psychopharmacology is an academic journal published by SAGE PUBLICATIONS LTD (ENGLAND). Identifiers: ISSN 0269-8811, eISSN 1461-7285. Indexed in SCIE, SCOPUS. Metrics: JIF 5.5, CiteScore 9.9, SJR 1.708, SNIP 1.37. JIF percentile 91.1% in its primary Web of Science category. Subject areas: CLINICAL NEUROLOGY, NEUROSCIENCES, PHARMACOLOGY & PHARMACY, PSYCHIATRY.
AI JOURNAL FINDER
Is your manuscript a fit for this journal?
Enter your title and abstract to compare with AI Journal Finder’s recommendations.
Articles published in this journal
Recent papers
- Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.
2026 · 1 citations
- Administration of an extrasynaptic δ-subunit GABAA receptor agonist in the prelimbic cortex attenuates methamphetamine sensitisation and relapse to methamphetamine-seeking behaviour in male rats.
2026
- Ten practical suggestions for setting up a psychedelic study.
2026
- Cardiovascular mortality and depression: A systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity
2026
- Clozapine-induced neutropenia: Prevalence and associated factors.
2026
Most cited papers
- Human Hallucinogen Research: Guidelines for Safety
2008 · 1,036 citations
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 · 1,024 citations
- 5-HT and mechanisms of defence
1991 · 964 citations
- Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology
2009 · 944 citations
- Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction
2014 · 837 citations